PASTEURELLA MULTOCIDA TOXIN--STRUCTURE AND ACTIVITY

多杀性巴氏杆菌毒素——结构和活性

基本信息

项目摘要

Pasteurella multocida is a pathogenic bacterium associated with the agricultural diseases pasteurellosis, hemorrhagic septicemia, dermonecrosis, and progressive atrophic rhinitis. P. multocida can cause severe complications in human infections from animal bites or scratches, respiratory infections, and exposure to animals during pregnancy. P. multocida toxin is an important virulence factor of P. multocida, and purified PMT alone is sufficient to experimentally induce progressive atrophic rhinitis. PMT appears to enter cells via receptor-mediated endocytosis and causes activation of signal transduction events and DNA synthesis. Recent studies from our laboratory have identified G alpha protein as the primary target of PMT action that activates the phosphatidylinositol-specific phospholipase C-beta 1 and the inositol triphosphate pathway in Xenopus oocytes. Studies from our laboratory have also shown that the N-terminus of PMT is important for this activity, and we have proposed a model for PMT's intracellular action. We have cloned the entire toxA gene (1285 residues) from P. multocida and have generated a number of deletion mutants, encoding residues 1-73, 1-293, 1-506, 506- 1285, and 1059-1285. Our long range goals are to use these recombinant proteins to understand the structure and mechanism of action of PMT at the molecular and biochemical level, both to facilitate future therapeutic intervention in the bacterial pathogenesis of P. multocida , as well as to provide insight into the molecular signalling events involved in the control of cell growth and differentiation. In particular, we hope to demonstrate the utility of PMT as a new biochemical tool for studying intracellular signalling pathways involving the Gq family of regulatory proteins. To achieve our goals, we propose the following: (1) To define the functional domains of the protein, so as to determine which of the toxin's domains are responsible for (1) binding to the eukaryotic cell receptors and (2) stimulating the intracellular signal transduction pathways. (2) To elucidate the molecular mechanism by which PMT activates Gq- protein, by determining whether PMT's activation of Gq-protein is caused by a covalent modification or by noncovalent interaction. (3) To test the hypothesis that PMT uncouples the ligand-regulated interaction between receptor and Gq-protein, using the Xenopus oocyte system overexpressing exogenous 5-HT2 receptor and Gqalpha-protein.
多杀性巴氏杆菌是一种致病性细菌, 农业疾病巴氏杆菌病,出血性败血症, 皮肤坏死和进行性萎缩性鼻炎 多杀性巴氏杆菌可导致 动物咬伤或抓伤引起的人类感染的严重并发症, 呼吸道感染和怀孕期间接触动物。 P. 多杀性巴氏杆菌毒素是巴氏杆菌的重要毒力因子, 单独纯化的PMT足以在实验上诱导进行性 萎缩性鼻炎PMT似乎通过受体介导的细胞内信号传导进入细胞。 内吞作用并引起信号转导事件和DNA的激活 合成.我们实验室最近的研究发现G α 蛋白作为PMT作用的主要靶点, 磷脂酰肌醇特异性磷脂酶C-β 1和肌醇 非洲爪蟾卵母细胞的三磷酸途径。我们实验室的研究 还表明PMT的N末端对于该活性很重要,并且 我们提出了PMT细胞内作用的模型。我们已经克隆 多杀性巴氏杆菌的完整toxA基因(1285个残基),并产生了 许多缺失突变体,编码残基1-73、1-293、1-506、506- 508、508 - 509、509 - 509、5 1285,1059-1285。我们的长期目标是利用这些重组 蛋白质,以了解PMT的结构和作用机制, 分子和生物化学水平,这两者都有助于未来 多杀性巴氏杆菌细菌发病机制的治疗干预 ,以及提供对分子信号事件的深入了解, 参与控制细胞生长和分化。在 特别是,我们希望证明PMT作为一种新的 用于研究细胞内信号传导途径的生化工具, Gq家族的调节蛋白。为了实现我们的目标,我们建议 如下: (1)确定蛋白质的功能结构域,从而确定 毒素的哪些结构域负责(1)与 真核细胞受体和(2)刺激细胞内信号 转导途径。 (2)为了阐明PMT激活Gq的分子机制, 蛋白质,通过确定是否引起PMT的Gq-蛋白质的活化, 通过共价修饰或通过非共价相互作用。 (3)为了检验PMT解偶联配体调节的 受体和Gq蛋白之间的相互作用,使用非洲爪蟾卵母细胞 过量表达外源性5-HT 2受体和Gq α蛋白的系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brenda A. Wilson其他文献

Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
白喉毒素和铜绿假单胞菌外毒素 A:活性位点结构和酶机制。
Effect of Antibiotic Treatment on the Gastrointestinal Microbiome of Free-Ranging Western Lowland Gorillas (Gorilla g. gorilla)
  • DOI:
    10.1007/s00248-016-0745-5
  • 发表时间:
    2016-03-16
  • 期刊:
  • 影响因子:
    4.000
  • 作者:
    Klára Vlčková;Andres Gomez;Klára J. Petrželková;Christopher A. Whittier;Angelique F. Todd;Carl J. Yeoman;Karen E. Nelson;Brenda A. Wilson;Rebecca M. Stumpf;David Modrý;Bryan A. White;Steven R. Leigh
  • 通讯作者:
    Steven R. Leigh

Brenda A. Wilson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brenda A. Wilson', 18)}}的其他基金

Neuronal-specific cargo-delivery platforms as post-exposure botulism therapies
作为暴露后肉毒杆菌疗法的神经元特异性货物递送平台
  • 批准号:
    8851508
  • 财政年份:
    2012
  • 资助金额:
    $ 10.03万
  • 项目类别:
Neuronal-specific cargo-delivery platforms as post-exposure botulism therapies
作为暴露后肉毒杆菌疗法的神经元特异性货物递送平台
  • 批准号:
    8471649
  • 财政年份:
    2012
  • 资助金额:
    $ 10.03万
  • 项目类别:
Neuronal-specific cargo-delivery platforms as post-exposure botulism therapies
作为暴露后肉毒杆菌疗法的神经元特异性货物递送平台
  • 批准号:
    8367174
  • 财政年份:
    2012
  • 资助金额:
    $ 10.03万
  • 项目类别:
Targeted antitoxin delivery platforms as post-exposure therapies for botulism
靶向抗毒素递送平台作为肉毒杆菌中毒的暴露后疗法
  • 批准号:
    7457963
  • 财政年份:
    2007
  • 资助金额:
    $ 10.03万
  • 项目类别:
Targeted antitoxin delivery platforms as post-exposure therapies for botulism
靶向抗毒素递送平台作为肉毒杆菌中毒的暴露后疗法
  • 批准号:
    7918949
  • 财政年份:
    2007
  • 资助金额:
    $ 10.03万
  • 项目类别:
Targeted antitoxin delivery platforms as post-exposure therapies for botulism
靶向抗毒素递送平台作为肉毒杆菌中毒的暴露后疗法
  • 批准号:
    7640765
  • 财政年份:
    2007
  • 资助金额:
    $ 10.03万
  • 项目类别:
Targeted antitoxin delivery platforms as post-exposure therapies for botulism
靶向抗毒素递送平台作为肉毒杆菌中毒的暴露后疗法
  • 批准号:
    7325538
  • 财政年份:
    2007
  • 资助金额:
    $ 10.03万
  • 项目类别:
PASTEURELLA MULTOCIDA TOXIN--STRUCTURE AND ACTIVITY
多杀性巴氏杆菌毒素——结构和活性
  • 批准号:
    6169281
  • 财政年份:
    1996
  • 资助金额:
    $ 10.03万
  • 项目类别:
Pasteurella multocida toxin: Structure and Activity
多杀性巴氏杆菌毒素:结构和活性
  • 批准号:
    7189132
  • 财政年份:
    1996
  • 资助金额:
    $ 10.03万
  • 项目类别:
Pasteurella multocida toxin: Structure and Activity
多杀性巴氏杆菌毒素:结构和活性
  • 批准号:
    7024490
  • 财政年份:
    1996
  • 资助金额:
    $ 10.03万
  • 项目类别:

相似海外基金

Intelligent cryo-electron microscopy of G protein-coupled receptors
G 蛋白偶联受体的智能冷冻电子显微镜
  • 批准号:
    23K23818
  • 财政年份:
    2024
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Cryo-electron microscopy determination of G protein-coupled receptor states
冷冻电镜测定 G 蛋白偶联受体状态
  • 批准号:
    DE230101681
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Discovery Early Career Researcher Award
Development of multidrug combination molecular targeted therapeutics based on G protein-coupled receptor interactions in glioblastoma
基于G蛋白偶联受体相互作用的胶质母细胞瘤多药组合分子靶向治疗的开发
  • 批准号:
    23K08551
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
RUI: Identifying reproductive roles for the Super-conserved Receptors Expressed in Brain (SREB) G protein-coupled receptor family using novel agonists and a comparative fish model
RUI:使用新型激动剂和比较鱼类模型确定脑中表达的超级保守受体 (SREB) G 蛋白偶联受体家族的生殖作用
  • 批准号:
    2307614
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Continuing Grant
The Role of Intermediate Conformations in G Protein-coupled Receptor Signaling
中间构象在 G 蛋白偶联受体信号传导中的作用
  • 批准号:
    10635763
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
India Link: Selective interactions between G protein-coupled receptors and conformationally selective arrestin variants
India Link:G 蛋白偶联受体与构象选择性抑制蛋白变体之间的选择性相互作用
  • 批准号:
    BB/T018720/1
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Research Grant
Architecture of inhibitory G protein signaling in the hippocampus
海马抑制性 G 蛋白信号传导的结构
  • 批准号:
    10659438
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
Molecular mechanisms of GPCR/G protein diseases and drug development
GPCR/G蛋白疾病的分子机制及药物开发
  • 批准号:
    23K07998
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research Initiation Award: Exploring Class A G-Protein Coupled Receptors (GPCRs)-Ligand Interaction through Machine Learning Approaches
研究启动奖:通过机器学习方法探索 A 类 G 蛋白偶联受体 (GPCR)-配体相互作用
  • 批准号:
    2300475
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Standard Grant
Structure and dynamics of class B1 G protein coupled receptors
B1类G蛋白偶联受体的结构和动力学
  • 批准号:
    DP230102776
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Discovery Projects
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了